Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Portfolio diet reduces risk factors for cardiovascular disease

Portfolio diet reduces risk factors for cardiovascular disease

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

'Hijacked' cell response to stress reveals potential therapeutic targets for leukemia

'Hijacked' cell response to stress reveals potential therapeutic targets for leukemia

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer announces FDA approval of biosimilar to Neupogen

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

New discovery could save millions of lives from fatal fungal infections

New discovery could save millions of lives from fatal fungal infections

Researchers unravel how ALL invades the central nervous system

Researchers unravel how ALL invades the central nervous system

CT scans may raise brain tumor risk

CT scans may raise brain tumor risk

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Researchers map family trees of cancer cells to understand how AML responds to new drug

Researchers map family trees of cancer cells to understand how AML responds to new drug

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

New findings refine link between clonal hematopoiesis and blood cancer risk

New findings refine link between clonal hematopoiesis and blood cancer risk

Researchers uncover molecular drivers of  a deadly pediatric cancer

Researchers uncover molecular drivers of a deadly pediatric cancer